Atrial fibrillation and frailty development in older patients. Do therapeutic options exert a protective effect? From physical function, mood and cognition to metabolic pathways and “inflammageing”. The CAFFE (Cardioversion of Atrial Fibrillation and Frailty in the Elderly) Study

Responsabile scientifico: prof. Diemberger Igor

Ente finanziatore: MUR

Durata: 18/10/2023 - 17/10/2025